Beruflich Dokumente
Kultur Dokumente
This article contains supplementary material available via the Internet at http://www.interscience.wiley.com/jpages/0885-3185/suppmat.
*Correspondence to: Jaime Kulisevsky, Movement Disorders Unit,
Neurology Department, Sant Pau Hospital, Sant Antoni M, Claret
167, 08025 Barcelona, Spain. E-mail: jkulisevsky@santpau.es
Received 2 October 2007; Accepted 6 February 2008
Published online 31 March 2008 in Wiley InterScience (www.
interscience.wiley.com). DOI: 10.1002/mds.22007
998
999
ing Scale (CDR),24 MCI when the score was 0.5, and
PDD wshen the score was one and when they met
294.1 criteria for PDD on the Diagnostic and Statistical
Manual of Mental Disorders, revised Fourth Edition
(DSM IV-TR).25 Patients with motor uctuations were
examined during the on state.
Sixty-one age-, sex- and education-matched healthy
subjects, most of whom were spouses or caregivers of
the patients, served as the control group. None of the
controls had cognitive complaints or prior history of
cardiovascular risk factors or neurological or psychiatric illness.
Informed consent to participate in the study was
obtained from all patients or caregivers, as appropriate,
and from controls. The study was approved by the
Local Ethics Committee.
Procedure and Assessment of the Psychometric
Properties of the Scale
The PD-CRS items were selected to cover the full
spectrum of cognitive changes seen in PD. We divided
the items as either subcortical-type or corticaltype, depending on the neural correlates reported in
previous neuropsychological and neuroimaging studies.
Description and rationale for the selection of the PDCRS items included in the initial version of the scale
(content validity) is provided in E-Appendix 1.
The initial PD-CRS included 10 subcortical-type
items (attention, working memory, Stroop test, phonemic, semantic, alternating, and action verbal uencies,
immediate and delayed verbal memory, clock drawing),
and two cortical-type items (naming, copy of a clock).
Each patient was scheduled for four visits. At the rst
visit, a neurologist (JP) administered the Mattis Dementia Rating Scale (MDRS)26 and classied patients into
cognitive groups according to the CDR. A neuropsychologist (GL) blinded to the MDRS and CDR scores
administered a comprehensive neuropsychological battery with validated cognitive tasks that assessed the
same cognitive domains as those evaluated by the PDCRS. To assess concurrent validity and test-retest reliability, the same neuropsychologist (GL) administered
the PD-CRS at the second and third visits. Inter-rater
reliability was assessed by another neuropsychologist
(CG) at the fourth visit. The interval between rst and
second visits was 2 weeks and the interval between second, third and fourth visits was 6 6 2 weeks.
Concurrent validity was assessed with the following
comparisons: total PD-CRS scores with total MDRS
scores; attention and working memory with the digit
span forward and backward subtests of the WAIS-III27;
verbal uencies with the verbal uencies in the WAIS-
1000
J. PAGONABARRAGA ET AL.
71.2 6 9.1
8.9 6 5.3
59.3%
123 6 17
8.2 6 5
8.8%
38.5%
39.6%
13.1%
0%
25.6 6 12
609.7 6 408
163.1 6 168
774.7 6 460
CG (n 5 61)
69 6 8.0
10.3 6 4
53.1%
138.3 6 2.9
0.13a
0.10a
0.49b
<0.0001a
1001
TABLE 2. Analysis of covariance (ANCOVA) between controls and PD cognitive groups (CgInt, MCI, and PDD), with age,
education, and UPDRS-III as covariates
Dependent Variable
Attention
Working memory
Phonemic uency
Semantic uency
Alternating uency
Action uency
Immediate verbal memory
Delayed verbal memory
Naming
Clock drawing
Copy of a clock
53.1
41.8
16.8
25.6
25.5
27.0
31.5
17.5
23.0
39.3
27.7
0.0004
0.0002
0.0001
0.0002
0.0002
0.0006
0.0001
0.0009
0.0003
0.0001
0.0003
PD: Parkinsons disease; CgInt: Cognitively intact; MCI: mild cognitive impairment; PDD: Parkinsons disease with dementia; PD-CRS: Parkinsons Disease-Cognitive Rating Scale; CDT: Clock Drawing Task.
analysis considering only PD patients with mild dementia (CDR 5 1; n 5 10) also showed this group to score
signicantly lower than the MCI group in the two
cortical-type items [naming (P < 0.001), copy of the
clock (P 5 0.004)], and in action VF (P 5 0.01).
No evidence of heteroscedasticity was found when
examining the residuals for each cognitive item in the
scale.
Multivariate Analysis. Stepwise logistic regression
analysis (forward: conditional) showed that naming
(P 5 0.046; OR 5 0.18, CI95% 0.320.96), action VF
(P 5 0.034; OR 5 0.21, CI95% 0.050.89), and immediate memory (P 5 0.02; OR 5 0.06, CI 95% 0.01
0.36) independently differentiated PDD from the PDND group. The MCI group was independently differentiated from CgInt patients by the alternating VF (P 5
0.008; OR 5 0.79, CI 95% 0.660.94) and delayed
memory (P 5 0.04; OR 5 0.75, CI 95% 0.560.99).
Selection and Clinimetric Assessment of the Final
Version of the PD-CRS. For their greater ability to
discriminate between cognitive groups, alternating and
action verbal uencies were nally selected. The computerized version of the Stroop test did not displayed
appropriate discriminative properties, so that this item
was excluded from the nal version of the scale.
Total scores of the nal version of the PD-CRS
showed a strong concurrent validity with the total
MDRS scores (ICC 5 0.87, CI 95% 0.820.90). The
individual items, total, cortical and subcortical scores
of the nal version of the PD-CRS showed also a high
test-retest and a inter-rater reliability, with ICC ranging
from 0.75 to 0.94, as well as a high internal consistency (Cronbachs a 5 0.82).
1002
J. PAGONABARRAGA ET AL.
The overall duration of the nal version of the PDCRS was 16 6 3.6 min in the PD-ND group and 24 6
7.8 min in the PDD group. The content, instructions
1003
1004
J. PAGONABARRAGA ET AL.
REFERENCES
1. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinsons disease. Mov Disord
2005;20:12551263.
2. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive prole of patients with newly diagnosed Parkinson disease. Neurology 2005;65:12391245.
3. Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological prole of patients with Parkinsons disease without dementia.
Dement Geriatr Cogn Disord 2003;15:126131.
4. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive
ability of an incident cohort of Parkinsons patients in the UK.
The CamPaIGN study. Brain 2004;127:550560.
5. Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R.
Neuropsychological characteristics of preclinical dementia in Parkinsons disease. Neurology 1995;45:16911696.
6. Ballard CG, Aarsland D, McKeith I, et al. Fluctuations in attention: PD dementia vs DLB with Parkinsonism. Neurology 2002;
59:17141720.
7. Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson
disease dementia. Neurology 2006;67:16051611.
8. Ito K, Nagano-Saito A, Kato T, et al. Striatal and extrastriatal
dysfunction in Parkinsons disease with dementia: a 6-[18F]uoro-L-dopa PET study. Brain 2002;125:13581365.
9. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinsons disease are accompanied
by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:63516356.
10. Hilker R, Thomas AV, Klein JC, et al. Dementia in Parkinson
disease: functional imaging of cholinergic and dopaminergic
pathways. Neurology 2005;65:17161722.
11. Dubois B, Pilon B, Lhermitte F, Agid Y. Cholinergic deciency
and frontal dysfunction in Parkinsons disease. Ann Neurol
1990;28:117121.
12. Burton EJ, McKeith IG, Burn DJ, Williams ED, OBrien JT.
Cerebral atrophy in Parkinsons disease with and without dementia: a comparison with Alzheimers disease, dementia with Lewy
bodies and controls. Brain 2004;127:791800.
1005
Items are administered to the subjects in the same order as presented below.
Words
LIGHT
SILK
SAND
EYELASH
RICE
TIE
BLACKBOARD
BICYCLE
STAR
LION
RING
FRAGRANCE
Score: 1 point for each word recalled. The highest number of words recalled in any one
trial is the score. (0-12)
2. Confrontation naming.
The subject is asked to name the line drawings shown on 20 consecutive cards. There is
no time limit for response, and only one trial is given. No semantic or phonemic cues are
provided. When objects are included in their context (bib, buckle, mane, hook, jingle bell,
and hoof), the examiner is allowed to indicate the part of the line drawing to be named.
Content:
Images (see line drawings at the end of
the appendix)
BIB
CANDLE
CHERRY
STOOL
ANCHOR
TURTLE
KITE
FISHBOWL
BULB
GUITAR
BUCKLE
MANE
HOOK
SCREWDRIVER
PANEL SCREEN
SAFETY PIN
JINGLE BELL
HOOF
EXTINGUISHER
DOOR BOLT
3. Sustained attention.
Instruction: An ascending series of letters and numbers are read to the subjects. The
subject is asked to report the number of letters in the sequence. Ten series of letters and
numbers are presented, divided into five levels of ascending complexity. Two training
series are provided at the beginning of the test.
Content:
Correct answer
2LT
2 letters
8A9
1 letter
2P654
1 letter
3A6KL
3 letters
B904LT
3 letters
3CP573
2 letters
Example
395L4ZA
3 letters
I1ASQ41
4 letters
75DA4TB2
4 letters
968437LC
2 letters
Z49ATD384
4 letters
95MD4SC3E
5 letters
4. Working memory.
Instructions: The examiner reads aloud a randomized list of numbers and letters ranging
in length from 2 to 6 letters and numbers. After each series the subject is asked to repeat
the numbers first, and then the letters. This test ends when the subject is unable to give
the correct answer in two consecutive series. Two training series are provided at the
beginning of the test.
Content:
Correct answer
L2T
2LT
8A9
89A
M3
3M
7P
7P
G8M
8GM
Example
9I6
96I
T04A
04TA
7V6J
76VJ
M64NI
64MNI
35SGC
35SCG
1R9VB3
193RVB
M274Z9
2749MZ
12
11
10
4
7
5
6
Unprompted
Copy
Yes
Yes No
No
Score: 1 point for each correct item. (0-10 for each task)
TIE
BLACKBOARD
BICYCLE
STAR
LION
RING
FRAGRANCE
Score: 1 point for each word recalled. (0-12)
SCORES
ITEM
Points
Subcortical and cortical PD-CRS scores were obtained by adding the raw scores of the
items within each group. Total scores on the PD-CRS were calculated by adding the
subcortical and cortical PD-CRS scores.
LINE DRAWINGS.
1. BIB
2. CANDLE
3. CHERRY
4. STOOL
5. ANCHOR
6. TURTLE
7. KITE
8. FISHBOWL
9. BULB
10. GUITAR
11. BUCKLE
12. MANE
13. HOOK
14. SCREWDRIVER
18. HOOF
19. EXTINGUISHER
- Verbal memory: Free recall immediate and delayed verbal memory are markedly
impaired in PD-ND2, 14 and their deterioration is indicative of PDD development. 10, 15
Impairment in free recall memory appears to be more related to the defective use of
memory stores due to working memory deficits, than a reduced capacity of
storing/consolidating new information in the temporal lobes.16 The specific task selected
was to recall as many words as possible from a 12-word list.
- Visuoconstructional skills/Clock drawing: PD-ND and PDD17 are associated with
marked visuospatial deficits.17, 18 Visuoconstructional abilities depend on the
functionality of both the prefrontal cortex and the posterior visual cortical areas.19 The
specific task selected for this cognitive function was the unprompted drawing of a clock
set at twenty-five minutes past ten,
2. Cortical-type cognitive items:
- Confrontation naming: Naming is normal in PD-ND20, 21 but deteriorates in PDD.20,
21
The decline in naming in PDD is even more rapid than in AD.22 Naming has been
mainly correlated with cortical activity in the anteromedial and posteromedial temporal
cortex.23, 24 In this task, participants were asked to name 20 line drawings, with no time
constraint.
- Visuoperceptual skills/Copy of a clock: To assess the functionality of the posterior
visual cortical areas, we assessed the copy of a clock after the unprompted drawing of
such a clock, which has been shown to partially separate the frontal-subcortical from the
posterior cortical component of this cognitive function.25 The task selected was the copy
of a clock set at twenty-five minutes past ten.
The initial PD-CRS included 10 subcortical-type items (attention, working memory,
Stroop test, four verbal fluencies, immediate and delayed verbal memory, clock
drawing), and two cortical-type items (naming, copy of a clock). Total score ranged
from 0 to 204, subcortical score from 0 to 174, and cortical score from 0 to 30, with
higher scores indicating a better functioning.
1.
Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with
Parkinson's disease 'on' and 'off' levodopa. Brain 1988;111:299-321.
2.
Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with
newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
3.
Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients
with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.
4.
Ballard CG, Aarsland D, McKeith I, O'Brien J, Gray A, Cormack F, et al. Fluctuations
in attention: PD dementia vs DLB with parkinsonism. Neurology 2002;59:1714-1720.
5.
Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, et al. Frontostriatal cognitive deficits at different stages of Parkinson's disease. Brain 1992;115:1727-1751.
6.
Bruck A, Aalto S, Nurmi E, Bergman J, Rinne JO. Cortical 6-[18F]fluoro-L-dopa
uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging
2005;26:891-898.
7.
Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in
early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural
circuitry. J Neurosci 2003;23:6351-6356.
8.
Cools R, Barker RA, Sahakian BJ, Robbins TW. Mechanisms of cognitive set flexibility
in Parkinson's disease. Brain 2001;124:2503-2512.
9.
Peterson BS, Kane MJ, Alexander GM, Lacadie C, Skudlarski P, Leung HC, et al. An
event-related functional MRI study comparing interference effects in the Simon and Stroop
tasks. Brain Res Cogn Brain Res 2002;13:427-440.
10.
Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R. Neuropsychological
characteristics of preclinical dementia in Parkinson's disease. Neurology 1995;45:1691-1696.
11.
Henry JD, Crawford JR. Verbal fluency deficits in Parkinson's disease: a meta-analysis.
J Int Neuropsychol Soc 2004;10:608-622.
12.
Piatt AL, Fields JA, Paolo AM, Koller WC, Troster AI. Lexical, semantic, and action
verbal fluency in Parkinson's disease with and without dementia. J Clin Exp Neuropsychol
1999;21:435-443.
13.
Zec RF, Landreth ES, Fritz S, Grames E, Hasara A, Fraizer W, et al. A comparison of
phonemic, semantic, and alternating word fluency in Parkinson's disease. Arch Clin
Neuropsychol 1999;14:255-264.
14.
Ivory SJ, Knight RG, Longmore BE, Caradoc-Davies T. Verbal memory in nondemented patients with idiopathic Parkinson's disease. Neuropsychologia 1999;37:817-828.
15.
Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with
Parkinson's disease in the United Kingdom. Mov Disord 2004;19:1043-1049.
16.
Appollonio I, Grafman J, Clark K, Nichelli P, Zeffiro T, Hallett M. Implicit and explicit
memory in patients with Parkinson's disease with and without dementia. Arch Neurol
1994;51:359-367.
17.
Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual
perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology
2004;63:2091-2096.
18.
Huber SJ, Freidenberg DL, Shuttleworth EC, Paulson GW, Christy JA.
Neuropsychological impairments associated with severity of Parkinson's disease. J
Neuropsychiatry Clin Neurosci 1989;1:154-158.
19.
Lee TM, Liu HL, Hung KN, Pu J, Ng YB, Mak AK, et al. The cerebellum's
involvement in the judgment of spatial orientation: a functional magnetic resonance imaging
study. Neuropsychologia 2005;43:1870-1877.
20.
Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance
on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy
bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol
Neurosurg Psychiatry 2003;74:1215-1220.
21.
Frank EM, McDade HL, Scott WK. Naming in dementia secondary to Parkinson's,
Huntington's, and Alzheimer's diseases. J Commun Disord 1996;29:183-197.
22.
Stern Y, Tang MX, Jacobs DM, Sano M, Marder K, Bell K, et al. Prospective
comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease
dementia. J Int Neuropsychol Soc 1998;4:279-284.
23.
Grossman M, McMillan C, Moore P, Ding L, Glosser G, Work M, et al. What's in a
name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease,
frontotemporal dementia and corticobasal degeneration. Brain 2004;127:628-649.
24.
Teipel SJ, Willoch F, Ishii K, Burger K, Drzezga A, Engel R, et al. Resting state
glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
Neurobiol Aging 2006;27:681-690.
25.
Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol
Neurosurg Psychiatry 1998;64:588-594.